Considerations for personalized neoantigen vaccination in Malignant glioma
Gavin P. Dunn, Ngima D. Sherpa, Jimmy Manyanga, Tanner Michael Johanns
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/j.addr.2022.114312
- Published
- Apr 26, 2022
- Venue
- Advanced Drug Delivery Reviews
- DOI
- 10.1016/j.addr.2022.114312
- PubMed
- 35487282
- Categories
- Glioma Diagnosis and Treatment
- Provenance
- openalex